跳至主要内容
临床试验/NCT01782859
NCT01782859已完成不适用

Effect of Steroids Given Over 24 Hours on Cytokine Release, Urinary Desmosine Level and Thrombogenic Markers in Patients Undergoing Unilateral Total Hip Replacement

Hospital for Special Surgery, New York1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Serum Prothrombin Fragment 1 and 2 (PF 1.2)

研究概览

简要总结

Studies have shown that surgery causes some reactions in your body consistent with inflammation. When the inflammation is extensive, it may affect different parts of the body including the lungs. Corticosteroids are commonly used to treat inflammation and are different from performance enhancing steroids associated with athletics. The purpose of this study is to determine the influence of low dose steroids given 3 times in a 24 hour period on thrombotic markers (markers that are associated with increased risks of clotting, a possible complication of surgery), interleukin (IL)-6 cytokine release (part of the stress response seen with surgery), and urine desmosine levels (a marker of lung injury) in a randomized placebo controlled trial patients undergoing total hip replacement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
50 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing unilateral total hip replacement with Drs. Douglas Padgett, Thomas Sculco, or Edwin Su.
  • Patients between the age of 50 and 90

排除标准

  • Patients on steroid therapy regardless of dose or duration of treatment or those requiring stress-dose steroids preoperatively
  • Patients who are smokers
  • Patients who have diabetes
  • Patients who are <50 and >90 years of age
  • Patients with history of prior difficulties tolerating corticosteroids

研究组 & 干预措施

Placebo

Placebo Comparator

Control group

干预措施: Placebo (for Prednisone) (Drug)

Prednisone/hydrocortisone

Active Comparator

Steroid group will receive the following:

  1. 20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
  2. 100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV

干预措施: Prednisone (Drug)

Prednisone/hydrocortisone

Active Comparator

Steroid group will receive the following:

  1. 20 mg prednisone pill to be taken in the morning of surgery prior to arrival to the hospital
  2. 100 mg hydrocortisone IV 8 hours after first dose of prednisone followed by 3. Second and last dose of 100 mg hydrocortisone IV

干预措施: Hydrocortisone (Drug)

结局指标

主要结局

Serum Prothrombin Fragment 1 and 2 (PF 1.2)

时间窗: First 24 hours after surgery

Plasmin-a 2 Antiplasmin Complex (PAP)

时间窗: First 24 hours after surgery

次要结局

  • Interleukin (IL)-6 Cytokine Release (Inflammatory Marker)(Participants will be followed from the time of surgery until discharge, expected average of 3-5 days)
  • Desmosine Level (Marker of Lung Injury)(Participants will be followed from the time of surgery until discharge, expected average of 3-5 days)
  • Pain at 3 Months Post-op(3 months postoperatively)

研究者

发起方
Hospital for Special Surgery, New York
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验